Rchr
J-GLOBAL ID:201801010309771919   Update date: May. 14, 2024

Tatsuya Fukuta

フクタ タツヤ | Tatsuya Fukuta
Affiliation and department:
Research field  (3): Pharmaceuticals - health and biochemistry ,  Pharmaceuticals - analytical and physicochemistry ,  Clinical pharmacy
Research keywords  (8): Cancer ,  Exosome ,  Extracellular vesicle ,  白血球 ,  膜タンパク質 ,  リポソーム ,  脳梗塞 ,  ドラッグデリバリーシステム
Research theme for competitive and other funds  (12):
  • 2023 - 2026 Development of functional exosomes by a one-step pharmaceutical process and their application for the treatment of brain diseases
  • 2022 - 2026 脳血管-神経ユニット・胎盤エクソソーム輸送系を軸とした胎盤-脳連関機構解明と応用
  • 2021 - 2024 ゲノム編集ツール臓器内直接送達システムによる生体内ダイレクトゲノム編集技術の開発
  • 2021 - 2023 Development of a novel DDS capable of overcoming the blood-brain barrier by fusion of mesenchymal stem cell-derived exosomes and cerebral vessel-targeting liposomes for ischemic stroke therapy
  • 2019 - 2023 ヒトウイルス受容体を介した血液脳関門突破機構に基づくエクソソームの脳細胞標的化
Show all
Papers (57):
  • Eigo Fukuda, Ibuki Fujiwara, Shoki Maruno, Kaiki Motomura, Seiya Endo, Arihiro Iwasaki, Tatsuya Fukuta, Atsushi Nakayama, Tetsuro Shinada. Total Synthesis of Bipenicilisorin and Assignment of the Absolute Configuration. Journal of natural products. 2024
  • Ninad Kumbhojkar, Supriya Prakash, Tatsuya Fukuta, Kwasi Adu-Berchie, Neha Kapate, Rocky An, Solomina Darko, Vineeth Chandran Suja, Kyung Soo Park, Alexander P Gottlieb, et al. Neutrophils bearing adhesive polymer micropatches as a drug-free cancer immunotherapy. Nature Biomedical Engineering. 2024
  • Mayumi Ikeda-Imafuku, Tatsuya Fukuta, Victor Tuan Giam Chuang, Tomohiro Sawa, Toru Maruyama, Masaki Otagiri, Tatsuhiro Ishida, Yu Ishima. Acute Kidney Injury Caused by Rhabdomyolysis Is Ameliorated by Serum Albumin-Based Supersulfide Donors through Antioxidative Pathways. Pharmaceuticals (Basel, Switzerland). 2024. 17. 1
  • Mayumi Ikeda, Tatsuya Fukuta, Yasunori Iwao, Masaki Otagiri, Toru Maruyama, Tatsuhiro Ishida, Yu Ishima. [Characterization of Supersulfide in Serum Albumin and Its Therapeutic Application]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2024. 144. 1. 51-56
  • Hiroyuki Koide, Chiaki Kiyokawa, Anna Okishima, Kaito Saito, Keiichi Yoshimatsu, Tatsuya Fukuta, Yu Hoshino, Tomohiro Asai, Yuri Nishimura, Yoshiko Miura, et al. Design of an Anti-HMGB1 Synthetic Antibody for In Vivo Ischemic/Reperfusion Injury Therapy. Journal of the American Chemical Society. 2023
more...
MISC (3):
Education (2):
  • 2013 - 2017 University of Shizuoka
  • 2007 - 2013 University of Shizuoka School of Pharmaceutical Sciences Division of Pharmaceutical Science
Professional career (1):
  • 博士(薬学) (静岡県立大学大学院 薬学研究院)
Work history (4):
  • 2021/04 - 現在 Wakayama Medical University Department of Physical Pharmaceutics, School of Pharmaceutical Sciences Lecturer
  • 2022/09 - 2023/09 Harvard John A. Paulson School of Engineering and Applied Sciences Visiting Scholar
  • 2017/04 - 2021/03 The University of Tokushima
  • 2014/04 - 2017/03 日本学術振興会特別研究員(DC1)
Committee career (3):
  • 2020/06 - 2021/06 公益社団法人 日本薬剤学会第36年会 実行委員
  • 2015/05 - 2016/05 第30回日本薬剤学会学生主催シンポジウムSNPEE2015 組織委員長
  • 2014/05 - 2015/05 第29回日本薬剤学会学生主催シンポジウムSNPEE2014 組織委員
Awards (19):
  • 2024/03 - 令和6年度日本薬学会物理系薬学部会奨励賞
  • 2024/01 - 公立大学法人和歌山県立医科大学 学術論文奨励賞
  • 2022/12 - 公立大学法人和歌山県立医科大学 特別優良教員理事長表彰
  • 2021/06 - 日本膜学会 2021年度日本膜学会膜学研究奨励賞
  • 2020/11 - Japan Pharmaceutical Association Chugoku-Shikoku Branch Encouragement Award
Show all
Association Membership(s) (5):
遺伝子・デリバリー研究会 ,  THE MEMBRANE SOCIETY OF JAPAN ,  THE ACADEMY OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, JAPAN ,  THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM ,  日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page